Results 161 to 170 of about 3,006,902 (314)

Enhancing college English writing through self-efficacy-based instruction. [PDF]

Front Psychol
Jiang H.
europepmc   +1 more source

Automatic Writing--A Correction [PDF]

, 1894

openalex   +1 more source

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

Large language model for interpreting the Paris classification of colorectal polyps. [PDF]

Endosc Int Open
Massimi D, Carlini L, Mori Y, Di Stefano L, Antonelli G, Rizkala T, Spadaccini M, de Sire R, Alfarone L, Lena C, D'Aprano A, Parasa S, Bisschops R, von Renteln D, O'Reilly SM, Savevski V, Sharma P, Rex DK, Bretthauer M, Demomi E, Hassan C, Repici A.   +21 more
europepmc   +1 more source

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source

Towards personalized medicine for refractory/relapsed follicular lymphoma patients: The Lupiae-Cantera study. [PDF]

Hemasphere
Dogliotti I, Tonino S, Conte L, Stepanishyna Y, Moita F, Brites Alves S, Jiménez-Ubieto A, Gonzalez de Villambrosia S, Cavallo F, Del Campo Garcia R, Zing N, Kersten MJ, Federico M, EHA LyG Cantera 2018.   +13 more
europepmc   +1 more source

IV. On short-hand writing [PDF]

Henry Upington
openalex   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Phylogenetic analysis of chikungunya virus in travellers returning from La Reunion Island. [PDF]

J Travel Med
Taieb F, Baidaliuk A, Durand A, Prot BSc M, Jidar K, Hochedez P, Consigny PH, Itani O, Simon-Loriere E.   +8 more
europepmc   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source